| - GRCh37:
- Chr7:72700127-74142190
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72701084-74142190
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72700942-74142190
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72700996-74142256
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72921550-74145628
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, RFC2, STX1A, TBL2, TMEM270, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72718123-74141784
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72645013-74142190
| BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D, ABHD11, ABHD11-AS1 | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72589515-74629034
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, GTF2IRD2, GTF2IRD2B, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NCF1, NSUN5, RCC1L, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72589195-74225562
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, GTF2IRD2, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NCF1, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:72718123-74142190
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh38:
- Chr7:73304277-74727414
| LOC113748409, STX1A, LOC121175346, LOC108254673, CLDN4, MLXIPL, LOC123956163, ABHD11, GTF2I, MIR4284, NSUN5, TRIM50, VPS37D, LOC113748407, MIR590, LOC121740686, LIMK1, LOC123956164, DNAJC30, GTF2IRD1, ELN-AS1, LOC123956162, LOC113748410, LOC123956160, FKBP6, GTF2I-AS1, TMEM270, FZD9, METTL27, LOC123956159, EIF4H, BCL7B, LAT2, CLIP2, CLDN3, MIR10525, TBL2, LOC121175345, LOC123956161, ELN, LOC113748411, RFC2, ABHD11-AS1, LOC111413044, LOC113748408, BUD23, BAZ1B | | Hb SS disease, Williams syndrome | Pathogenic (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr7:73452039
- GRCh38:
- Chr7:74037709
| ELN | L56fs, L46fs | Supravalvar aortic stenosis, Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Williams syndrome | Pathogenic/Likely pathogenic (Mar 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73469099
- GRCh38:
- Chr7:74054769
| ELN | G340R, G348R, G370R, G374R, G384R, G379R, G389R | Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, not provided | Uncertain significance (Jan 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73471985
- GRCh38:
- Chr7:74057655
| ELN | A448E, A487E, A458E, A463E | not provided, Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, Supravalvar aortic stenosis | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73475600-73478833
| ELN | | Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis, Williams syndrome
| not provided | no assertion provided |
| - GRCh37:
- Chr7:72903655
- GRCh38:
- Chr7:73489325
| BAZ1B | R254* | Williams syndrome | Uncertain significance (Oct 27, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr7:73457474
- GRCh38:
- Chr7:74043144
| ELN | G123R, G125R, G130R, G135R, G140R | Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis, Williams syndrome, not provided | Uncertain significance (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73457452
- GRCh38:
- Chr7:74043122
| ELN | | Supravalvar aortic stenosis, Williams syndrome, Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis | Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:71847968-73391310
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CALN1, CLDN3, CLDN4, DNAJC30, FKBP6, FZD9, METTL27, MLXIPL, NSUN5, POM121, STX1A, TBL2, TMEM270, TRIM50, TRIM74, TYW1B, VPS37D | | Williams syndrome | Likely pathogenic (Mar 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr7:73474344
- GRCh38:
- Chr7:74060014
| ELN, ELN-AS1 | V426M, V434M, V482M, V486M, V491M, V496M, V501M, V505M, V515M, V520M, V521M, V544M | Williams syndrome, Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis, Supravalvar aortic stenosis, Inborn genetic diseases, not provided
| Uncertain significance (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73187643-73501025
| CLDN4, ELN, LIMK1, METTL27, TMEM270 | | Williams syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:73450869
- GRCh38:
- Chr7:74036539
| ELN | | Williams syndrome, Supravalvar aortic stenosis | Conflicting interpretations of pathogenicity (Jul 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:73466257
- GRCh38:
- Chr7:74051927
| ELN | V254A, V262A, V288A, V293A, V298A, V284A, V303A | Williams syndrome | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr7:73469050-73469051
- GRCh38:
- Chr7:74054720-74054721
| ELN | S333fs, S359fs, S369fs, S325fs, S355fs, S364fs, S374fs | Williams syndrome | Pathogenic (Sep 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:73442552
- GRCh38:
- Chr7:74028222
| ELN | G12V | Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, Supravalvar aortic stenosis, not provided, Cutis laxa, autosomal dominant 1
| Uncertain significance (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73469098
- GRCh38:
- Chr7:74054768
| ELN | Y369*, Y373*, Y388*, Y339*, Y378*, Y383*, Y347* | Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis, Williams syndrome, Supravalvar aortic stenosis | Pathogenic/Likely pathogenic (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:72657228-74160300
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic (Dec 2, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr7:73011578
- GRCh38:
- Chr7:73597248
| MLXIPL | A513T | not provided, Williams syndrome | Benign/Likely benign (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73012019
- GRCh38:
- Chr7:73597689
| MLXIPL | | not provided, Williams syndrome | Benign/Likely benign (Jul 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:72772522-74133319
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, RFC2, STX1A, TBL2, TMEM270, VPS37D | | Williams syndrome | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:72700996-74142190
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:72744494-76038818
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CASTOR2, CCL24, CCL26, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, GTF2IRD2, GTF2IRD2B, HIP1, HSPB1, LAT2, LIMK1, MDH2, METTL27, MIR590, MLXIPL, NCF1, POM121C, POR, RCC1L, RFC2, RHBDD2, SPDYE5, SRRM3, SSC4D, STX1A, STYXL1, TBL2, TMEM120A, TMEM270, TRIM73, VPS37D, YWHAG, ZP3 | | Williams syndrome | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:72744494-74339044
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2I, GTF2IRD1, GTF2IRD2, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NCF1, RFC2, STX1A, TBL2, TMEM270, VPS37D | | Williams syndrome | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:72721449-73959106
| ABHD11, ABHD11-AS1, BAZ1B, BCL7B, BUD23, CLDN3, CLDN4, CLIP2, DNAJC30, EIF4H, ELN, FKBP6, FZD9, GTF2IRD1, LAT2, LIMK1, METTL27, MIR590, MLXIPL, NSUN5, RFC2, STX1A, TBL2, TMEM270, TRIM50, VPS37D | | Williams syndrome | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:73471771
- GRCh38:
- Chr7:74057441
| ELN | G473S | not provided, Supravalvar aortic stenosis, Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Williams syndrome, Stroke
| Uncertain significance (Dec 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73469087
- GRCh38:
- Chr7:74054757
| ELN | A380T, A344T, A385T, A375T, A336T, A366T, A370T | Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis | Uncertain significance (Apr 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73474759
- GRCh38:
- Chr7:74060429
| ELN, ELN-AS1 | V559I, V588I, V530I, V545I, V470I, V478I, V511I, V535I, V540I, V549I, V564I, V565I | Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, not provided, Supravalvar aortic stenosis, Inborn genetic diseases
| Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73455551
- GRCh38:
- Chr7:74041221
| ELN | G68R, G58R | Supravalvar aortic stenosis, not provided, Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, Inborn genetic diseases
| Uncertain significance (Aug 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73470621-73470644
- GRCh38:
- Chr7:74056291-74056314
| ELN | | not provided, Williams syndrome, Supravalvar aortic stenosis
| Conflicting interpretations of pathogenicity (Dec 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:73456960
- GRCh38:
- Chr7:74042630
| ELN | | Cutis laxa, autosomal dominant 1, Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, not specified, Supravalvar aortic stenosis
| Benign/Likely benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73477975
- GRCh38:
- Chr7:74063645
| ELN | G648E, G600E, G653E, G654E, G710E, G559E, G567E, G634E, G638E, G624E, G629E, G619E | Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1, Williams syndrome, not provided, Supravalvar aortic stenosis | Uncertain significance (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73477690
- GRCh38:
- Chr7:74063360
| ELN | A637T, A589T, A642T, A699T, A548T, A613T, A618T, A623T, A643T, A556T, A608T, A627T | Williams syndrome, Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis
| Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:73442448
- GRCh38:
- Chr7:74028118
| ELN | | Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, Cutis laxa, autosomal dominant, Supravalvar aortic stenosis | Uncertain significance (Oct 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73474484-73474485
- GRCh38:
- Chr7:74060154-74060155
| ELN, ELN-AS1 | A442F, A507F, A531F, A536F, A517F, A521F, A450F, A502F, A512F, A537F, A560F | Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, not specified | Uncertain significance (Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73449703
- GRCh38:
- Chr7:74035373
| ELN | G31E | Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1 | Uncertain significance (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:73462008
- GRCh38:
- Chr7:74047678
| ELN | G216V, G172V, G206V, G211V, G221V | Cutis laxa, autosomal dominant 1, Williams syndrome, Supravalvar aortic stenosis, not provided, Supravalvar aortic stenosis, Cutis laxa, autosomal dominant 1
| Conflicting interpretations of pathogenicity (Oct 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:73480332
- GRCh38:
- Chr7:74066002
| ELN | | Supravalvar aortic stenosis, Williams syndrome, Cutis laxa, autosomal dominant 1, Supravalvar aortic stenosis, Cutis laxa, autosomal dominant, not specified
| Benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |